CAR-NK cell therapy for hematologic malignancies: advances, challenges and optimization strategies

Weitong Liu1, Huilei Miao2, Li Weng3

  • 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Molecular Cancer
|March 26, 2026
PubMed
Abstract

No abstract available in PubMed .